GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » Research & Development

Cannabist Company Holdings (NEOE:CBST) Research & Development : C$0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cannabist Company Holdings's Research & Development for the three months ended in Mar. 2024 was C$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.0 Mil.


Cannabist Company Holdings Research & Development Historical Data

The historical data trend for Cannabist Company Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Research & Development Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Cannabist Company Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cannabist Company Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (NEOE:CBST) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Cannabist Company Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings (NEOE:CBST) Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc Formerly Columbia Care Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under Amber, ClaraCeed, Press, Platinum label, Platinum Partners, Seed & Starin, and Triple 777 brands.
Executives
Alison Worthington Director

Cannabist Company Holdings (NEOE:CBST) Headlines

No Headlines